Document Detail


End-of-life options for patients with advanced heart failure.
MedLine Citation:
PMID:  20585999     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Heart failure is a progressive disease with significant morbidity and mortality, but prognostication often is difficult. Many of the evidence-based therapies for heart failure provide symptomatic benefit, but may have intolerable side effects for patients with advanced disease. At the end of life, there is evidence of varying strengths for pharmacologic and nonpharmacologic relief of common symptoms like dyspnea, fatigue, pain, and depression. Patients also may benefit from inotropic therapy, ventricular assist devices, and hospice care. It is important for physicians to encourage patients to formulate advance directives, including decisions about do not resuscitate orders and deactivation of implantable cardioverter-defibrillators and ventricular assist devices.
Authors:
Judith Z Goldfinger; Eric D Adler
Related Documents :
19833639 - Right ventricular failure after left ventricular assist device implantation with concom...
19446789 - Ventricular assistance after tricuspid valve replacement for carcinoid heart disease.
16897929 - Inspiratory muscle training in a patient with left ventricular assist device.
16270359 - Successful high-risk coronary angioplasty in a patient with cardiogenic shock under cir...
3506089 - The human heart: vault of the soul or pump?
1521899 - Mechanical bridge to transplantation with the vienna heart in tah and lvad configuration.
16820629 - Metabolic syndrome is associated with faster degeneration of bioprosthetic valves.
11416269 - The rational for the use of à -blockers in the treatment of congestive heart failure.
25337489 - High sensitivity troponins and conventional troponins at the bedside.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current heart failure reports     Volume:  7     ISSN:  1546-9549     ISO Abbreviation:  Curr Heart Fail Rep     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-07-19     Completed Date:  2010-10-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101196487     Medline TA:  Curr Heart Fail Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  140-7     Citation Subset:  IM    
Affiliation:
Department of Medicine, Mount Sinai Medical Center, One Gustave L. Levy Place, Box 1118, New York, NY 10029, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiotonic Agents / therapeutic use
Defibrillators, Implantable
Heart Failure / complications,  therapy*
Heart-Assist Devices
Hospice Care
Humans
Palliative Care / methods*
Prognosis
Resuscitation Orders
Terminal Care / methods*
Chemical
Reg. No./Substance:
0/Cardiotonic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variation in the vitamin D receptor gene is not associated with risk of colorectal cancer in the Cze...
Next Document:  Quality-of-Life Measurements Versus Disease Activity in Systemic Lupus Erythematosus.